En enkelt peroral dosis på 30 mg reducerer den basale sekretion med cirka 70%, og patienternes symptomer lindres derfor fra den allerførste dosis.
A single oral dose of 30 mg reduces basal secretion by about 70%, and the patients' symptoms are consequently relieved starting from the very first dose.